Insider · CIK 0001206872

USMAN NASSIM

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001206872

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-28	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,452 sh	$6.93	+$23.9K	5,088
2024-06-28	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−3,452 sh	$12.00	−$41.4K	1,636
2024-06-28	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,452 sh	—	—	278,200
2024-05-01	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$6.93	+$139K	21,636
2024-05-01	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−14.9K sh	$13.86	−$207K	6,736
2024-05-01	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−5,000 sh	$14.90	−$74.5K	1,736
2024-05-01	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−100 sh	$15.63	−$1,563	1,636
2024-05-01	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	281,652
2024-04-01	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$6.93	+$139K	21,636
2024-04-01	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−20K sh	$16.15	−$323K	1,636
2024-04-01	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	301,652
2024-03-15	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$6.93	+$139K	21,636
2024-03-15	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−20K sh	$17.26	−$345K	1,636
2024-03-15	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	321,652
2023-10-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+342K sh	—	—	341,652
2023-10-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,866 sh	—	—	1,866
2023-08-31	GYREGYRE THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−24.541 sh	—	—	0
2023-08-31	GYREGYRE THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8.456 sh	—	—	0
2023-08-31	GYREGYRE THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−1.168 sh	—	—	0
2022-08-09	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+3,250 sh	$0.47	+$1,527.5	24,541
2022-02-09	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+3,250 sh	$0.46	+$1,495	21,291
2021-08-09	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+867 sh	$3.62	+$3,138.54	18,041
2021-04-05	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$4.63	+$23.2K	17,174
2021-04-05	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	259,783
2021-02-09	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+582 sh	$4.81	+$2,799.42	12,174
2021-02-08	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+140K sh	—	—	140,000
2021-02-08	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+140K sh	—	—	140,000
2020-08-10	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+582 sh	$4.81	+$2,799.42	11,592
2020-03-13	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+4,000 sh	$3.91	+$15.6K	11,010
2020-02-10	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+430 sh	$6.23	+$2,678.9	7,010
2020-01-23	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2019-08-12	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+413 sh	$6.51	+$2,688.63	6,580
2019-05-21	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,400 sh	$4.63	+$20.4K	10,567
2019-05-21	GYREGYRE THERAPEUTICS, INC.G Gift	Director	GGift	−4,400 sh	—	—	6,167
2019-05-21	GYREGYRE THERAPEUTICS, INC.G Gift	Director	GGift	+4,400 sh	—	—	8,456
2019-05-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,400 sh	—	—	264,783
2019-02-11	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+350 sh	$7.04	+$2,464	6,167
2019-01-31	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,729 sh	$4.63	+$26.5K	11,041
2019-01-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,729 sh	—	—	269,271
2019-01-24	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2018-07-30	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2018-04-09	GYREGYRE THERAPEUTICS, INC.G Gift	Director	GGift	−88 sh	—	—	0
2018-04-09	GYREGYRE THERAPEUTICS, INC.G Gift	Director	GGift	+88 sh	—	—	4,144
2018-04-04	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+88 sh	$4.63	+$407.44	88
2018-04-04	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−88 sh	—	—	274,912
2018-01-12	GYREGYRE THERAPEUTICS, INC. · Stock Option(Right to Buy)A Award	Director	AAward	+95K sh	—	—	95,000
2017-07-11	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+275K sh	—	—	275,000
2016-06-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)J Other	Director	JOther	0 sh	—	—	0
2016-06-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-12-17	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+4,000 sh	$2.00	+$8,000	78,375

Recent filings

Accepted (ET)
Jul 14
USMAN NASSIM0001140361-24-032024
SEC(opens sec.gov)
May 24
USMAN NASSIM0001140361-24-024125
SEC(opens sec.gov)
Apr 34
USMAN NASSIM0001140361-24-017566
SEC(opens sec.gov)
Mar 194
USMAN NASSIM0001140361-24-014164
SEC(opens sec.gov)
Nov 14
USMAN NASSIM0001140361-23-050616
SEC(opens sec.gov)
Sep 14
USMAN NASSIM0001140361-23-042367
SEC(opens sec.gov)
Aug 104
USMAN NASSIM0001209191-22-045256
SEC(opens sec.gov)

Companies

Address

260 LITTLEFIELD AVENUE

SOUTH SAN FRANCISCO, CA, 94080